dorsaVi (ASX:DVL) projects 2x battery life and 25-50% fewer sensors as its RRAM-neuromorphic roadmap targets the exoskeleton intelligence layer.
Small Caps Stocks
Evion Group (ASX:EVG) reports US$530k EBITDA from its Panthera expandable graphite JV at a quarter of capacity, with a 54.5% gross margin.
Lac Gold (ASX:LAC) reports a 1,580 g/t gold hit at Astoria as Phase 2 drilling at the Rouyn Project targets a materially larger resource.
Yojee (ASX:YOJ) signs Wayfinder as the second MOSAIC commercial customer, completing the freight matrix ahead of the September 2026 commercial release.
American West Metals (ASX:AW1) resampled historical core at West Desert returns 1,065g/t silver and 155g/t indium, with resource upgrade pathway opening up.
Control Bionics (ASX:CBL) lines up a 1,000-unit NextLevel LOI, US distribution deals and an Apple BCI release targeted for Q3 2026.
EBR Systems (ASX:EBR) has cleared a key CMS gate, with a National Coverage Determination for WiSE now tracking to a March 2027 Medicare decision.
Island Pharmaceuticals (ASX:ILA) starts GMP manufacturing of Galidesivir with PI Health Sciences, the last big step before a pivotal Marburg FDA submission.
Urbanise (ASX:UBN) unveils NAB banking integration, a branded Owners Portal and Strata upgrades targeting a A$20bn-plus annual strata payments flow.
Propel Funeral Partners (ASX:PFP) unveils three NZ acquisitions worth up to A$9.1m and FY26 guidance showing flat EBITDA against FY25.
